With Katherine Ellen Foley and Emily Martin.
On Tap
— Gottlieb, Giroir tussle after FDA cracks down on kratom.
— Clinical laboratories argue that FDA doesn’t have the authority to require premarket review of laboratory-developed tests.
It’s Tuesday, welcome back to Prescription Pulse. We’re still slack-jawed about these century-old lung samples being studied for 1918 flu virus mutations.
SUBSCRIBE TO "THE RECAST" TODAY: Power is shifting in Washington and in communities across the country. More people are demanding a seat at the table, insisting that politics is personal and not all policy is equitable. The Recast is a twice-weekly newsletter that explores the changing power dynamics in Washington and breaks down how race and identity are recasting politics and policy in America. Get fresh insights, scoops and dispatches on this crucial intersection from across the country and hear critical new voices that challenge business as usual. Don't miss out, SUBSCRIBE. Thank you to our sponsor, Intel.